Internal Medicine - Issue 4/2015
Reviews
291
The position of new antidiabetics in clinical practice: SGLT2 vs DPP4 inhibitors
Jan Šoupal, Martin Prázný
304
312
Possibilities of therapy GLP1 RA for diabetics with nephropathy
Alena Adamíková
316
Treatment of GLP1 receptor agonists and body mass control
Petr Žák, Jindřich Olšovský
321
Treatment of an elderly patients with diabetes
Zdeněk Rušavý, Michal Žourek
328
Issues of infection related to diabetic foot syndrome
MUDr. Milan Flekač, Ph.D.
335
Treatment of hypertension in diabetes mellitus
Jiří Widimský Jr
340
355
361
The microbial flora in the digestive tract and diabetes
Štěpán Svačina
365
Myokines – muscle tissue hormones
Zuzana Stránská, Štěpán Svačina
Original Contributions
295
Do diabetologists choose a therapy rationally?
Basic results of the PROROK project (A prospective observation project to assess the relevance of the difference between fasting glycemia and postprandial glycemia to estimation of success of type 2 diabetes therapy)
Basic results of the PROROK project (A prospective observation project to assess the relevance of the difference between fasting glycemia and postprandial glycemia to estimation of success of type 2 diabetes therapy)
Denisa Janíčková Žďárská, Pavlína Piťhová, Tomáš Pavlík, Milan Kvapil
346
Glycation of lens proteins in diabetes and its non-invasive assessment – first experience in the Czech Republic
Jan Škrha Jr, Jan Šoupal, Martin Prázný, Jan Škrha
351
miRNA-192, miRNA-21 and miRNA-200: new pancreatic cancer markers in diabetic patients?
Pavel Škrha, Aleš Hořínek, Michal Anděl, Jan Škrha
Internal Medicine
2015 Issue 4
Most read in this issue
- Myokines – muscle tissue hormones
- The treatment of diabetes in patients with liver and renal impairment
- Treatment of GLP1 receptor agonists and body mass control
- Treatment of hypertension in diabetes mellitus